Molecular Quality Controls Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Description
Market Overview:
The Molecular Quality Controls Market is projected to grow from USD 218.5 million in 2024 to USD 568.64 million by 2032, at a robust compound annual growth rate (CAGR) of 12.7% during the forecast period.
This market is driven by the increasing demand for advanced diagnostic tools, the rising prevalence of infectious diseases, and the growing adoption of personalized medicine. Regulatory mandates for laboratory accreditation and the need to ensure accurate and reliable diagnostic results further contribute to market expansion. Technological advancements in molecular diagnostics, such as PCR and next-generation sequencing (NGS), have spurred the need for high-quality control materials to validate testing accuracy. Additionally, the growing emphasis on precision diagnostics and the integration of AI and automation in laboratory workflows has significantly enhanced the demand for robust quality control solutions. Emerging economies are witnessing substantial growth in healthcare infrastructure and diagnostic labs, boosting market prospects. Collaborations between diagnostic companies and quality control providers have led to innovations in control materials, further supporting market growth. Furthermore, the increased focus on early disease detection and efficient diagnostic systems underscores the essential role of molecular quality controls in modern healthcare.
Market Drivers:
Advancements in Molecular Diagnostics Technology:
Technological advancements in molecular diagnostic tools, including polymerase chain reaction (PCR), next-generation sequencing (NGS), and digital PCR, are driving the demand for high-quality molecular quality control products. These cutting-edge techniques require reliable control materials to maintain testing accuracy and reproducibility. For instance, Bio-Rad Laboratories offers advanced molecular quality controls for NGS and PCR applications. Innovations in multiplex assays and automation further emphasize the importance of quality control, enabling laboratories to handle high-throughput testing efficiently.
Segments:
By Product:
Independent Controls
Instrument-Specific Controls
Polymerase Chain Reaction (PCR)
DNA Sequencing & NGS
Other Technologies
By Analyte Type:
Single-Analyte Controls
Multi-Analyte Controls
By Application:
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Other Applications
By End User:
Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Other End Users
By Geography:
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
Asia Pacific (China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific)
Latin America (Brazil, Argentina, Rest of Latin America)
Middle East & Africa (GCC Countries, South Africa, Rest of the Middle East and Africa)
Key Players:
F. Hoffmann-La Roche Ltd. (Switzerland)
Bio-Rad Laboratories, Inc. (U.S.)
Danaher Corporation (U.S.)
Thermo Fisher Scientific, Inc. (U.S.)
Randox Laboratories Ltd. (U.K.)
Abbott Laboratories (U.S.)
LGC Limited (U.K.)
Seegene Inc. (South Korea)
Microbiologics, Inc. (U.S.)
Grifols, S.A. (Spain)
The Molecular Quality Controls Market is projected to grow from USD 218.5 million in 2024 to USD 568.64 million by 2032, at a robust compound annual growth rate (CAGR) of 12.7% during the forecast period.
This market is driven by the increasing demand for advanced diagnostic tools, the rising prevalence of infectious diseases, and the growing adoption of personalized medicine. Regulatory mandates for laboratory accreditation and the need to ensure accurate and reliable diagnostic results further contribute to market expansion. Technological advancements in molecular diagnostics, such as PCR and next-generation sequencing (NGS), have spurred the need for high-quality control materials to validate testing accuracy. Additionally, the growing emphasis on precision diagnostics and the integration of AI and automation in laboratory workflows has significantly enhanced the demand for robust quality control solutions. Emerging economies are witnessing substantial growth in healthcare infrastructure and diagnostic labs, boosting market prospects. Collaborations between diagnostic companies and quality control providers have led to innovations in control materials, further supporting market growth. Furthermore, the increased focus on early disease detection and efficient diagnostic systems underscores the essential role of molecular quality controls in modern healthcare.
Market Drivers:
Advancements in Molecular Diagnostics Technology:
Technological advancements in molecular diagnostic tools, including polymerase chain reaction (PCR), next-generation sequencing (NGS), and digital PCR, are driving the demand for high-quality molecular quality control products. These cutting-edge techniques require reliable control materials to maintain testing accuracy and reproducibility. For instance, Bio-Rad Laboratories offers advanced molecular quality controls for NGS and PCR applications. Innovations in multiplex assays and automation further emphasize the importance of quality control, enabling laboratories to handle high-throughput testing efficiently.
Segments:
By Product:
Independent Controls
Instrument-Specific Controls
Polymerase Chain Reaction (PCR)
DNA Sequencing & NGS
Other Technologies
By Analyte Type:
Single-Analyte Controls
Multi-Analyte Controls
By Application:
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Other Applications
By End User:
Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Other End Users
By Geography:
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
Asia Pacific (China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific)
Latin America (Brazil, Argentina, Rest of Latin America)
Middle East & Africa (GCC Countries, South Africa, Rest of the Middle East and Africa)
Key Players:
F. Hoffmann-La Roche Ltd. (Switzerland)
Bio-Rad Laboratories, Inc. (U.S.)
Danaher Corporation (U.S.)
Thermo Fisher Scientific, Inc. (U.S.)
Randox Laboratories Ltd. (U.K.)
Abbott Laboratories (U.S.)
LGC Limited (U.K.)
Seegene Inc. (South Korea)
Microbiologics, Inc. (U.S.)
Grifols, S.A. (Spain)
Table of Contents
196 Pages
- CHAPTER NO. 1: INTRODUCTION
- 1.1.1. Report Description
- Purpose of the Report
- USP & Key Offerings
- 1.1.2. Key Benefits for Stakeholders
- 1.1.3. Target Audience
- 1.1.4. Report Scope
- CHAPTER NO. 2: EXECUTIVE SUMMARY
- 2.1. [Molecular Quality Controls Market] Snapshot
- [Molecular Quality Controls Market], 2018 - 2032 (USD Million)
- CHAPTER NO. 3: [Molecular Quality Controls Market] – INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Market Opportunities
- 3.5. Porter’s Five Forces Analysis
- CHAPTER NO. 4: ANALYSIS COMPETITIVE LANDSCAPE
- 4.1. Company Market Share Analysis – 2023
- 4.2. [Molecular Quality Controls Market] Company Revenue Market Share, 2023
- 4.3. Company Assessment Metrics, 2023
- 4.4. Start-ups /SMEs Assessment Metrics, 2023
- 4.5. Strategic Developments
- 4.6. Key Players Product Matrix
- CHAPTER NO. 5: PESTEL & ADJACENT MARKET ANALYSIS
- CHAPTER NO. 6: [Molecular Quality Controls Market] – BASED ON [Based on Product] ANALYSIS
- CHAPTER NO. 7: [Molecular Quality Controls Market] – BASED ON [Based on Analyte Type] ANALYSIS
- CHAPTER NO. 8: [Molecular Quality Controls Market] – BASED ON [Based on Application] ANALYSIS
- CHAPTER NO. 9: [Molecular Quality Controls Market] – BASED ON [Based on End User] ANALYSIS
- CHAPTER NO. 10: [Molecular Quality Controls Market] – BASED ON [Based on the Geography] ANALYSIS
- CHAPTER NO. 11: COMPANY PROFILES
- 11.1. F. Hoffmann-La Roche Ltd. (Switzerland)
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio
- 11.1.3. SWOT Analysis
- 11.1.4. Business Strategy
- 11.1.5. Financial Overview
- 11.2. Bio-Rad Laboratories, Inc. (US)
- 11.3. Danaher Corporation (US)
- 11.4. Thermo Fisher Scientific, Inc. (US)
- 11.5. Randox Laboratories Ltd. (UK)
- 11.6. Abbott Laboratories (US)
- 11.7. LGC Limited (UK)
- 11.8. Seegene Inc. (South Korea)
- 11.9. Microbiologics, Inc. (US)
- 11.10. Grifols, S.A. (Spain)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
